SOD1 and amyotrophic lateral sclerosis: In vivo studies also reveal that the accumulation of ALS SOD1 variant SOD1G93A in the IMS leads to activation of the UPRmt [356], consistent with other studies showing that activation of the UPRmt precedes disease onset and increases throughout disease progression in ALS mutant mice [357].